Xu K - Search Results

1

Silencing protein kinase C ζ by microRNA-25-5p activates AMPK signaling and inhibits colorectal cancer cell proliferation.

Zhang S, Zhang Y, Cheng Q, Ma Z, Gong G, Deng Z, Xu K, Wang G, Wei Y, Zou X. Zhang S, et al. Among authors: xu k. Oncotarget. 2017 Jun 27;8(39):65329-65338. doi: 10.18632/oncotarget.18649. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029434 Free PMC article.

2

AZD5153, a novel BRD4 inhibitor, suppresses human thyroid carcinoma cell growth in vitro and in vivo.

Xu K, Chen D, Qian D, Zhang S, Zhang Y, Guo S, Ma Z, Wang S. Xu K, et al. Biochem Biophys Res Commun. 2018 May 15;499(3):531-537. doi: 10.1016/j.bbrc.2018.03.184. Epub 2018 Mar 31. Biochem Biophys Res Commun. 2018. PMID: 29596834

3

ARV-825-induced BRD4 protein degradation as a therapy for thyroid carcinoma.

He L, Chen C, Gao G, Xu K, Ma Z. He L, et al. Among authors: xu k. Aging (Albany NY). 2020 Mar 12;12(5):4547-4557. doi: 10.18632/aging.102910. Epub 2020 Mar 12. Aging (Albany NY). 2020. PMID: 32163373 Free PMC article.

4

Association Between Red Blood Cell Distribution Width and Thyroid Function.

Zhou G, Ai Y, Guo S, Chen Q, Feng X, Xu K, Wang G, Ma C. Zhou G, et al. Among authors: xu k. Front Endocrinol (Lausanne). 2022 Jan 18;12:807482. doi: 10.3389/fendo.2021.807482. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35116009 Free PMC article.

5

The Association Between Serum Palmitic Acid and Thyroid Function.

Zhou G, Xu Y, Zhai Y, Gong Z, Xu K, Wang G, Sun C, Ma C. Zhou G, et al. Among authors: xu k, xu y. Front Endocrinol (Lausanne). 2022 May 3;13:860634. doi: 10.3389/fendo.2022.860634. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35592784 Free PMC article.

6

Deciphering the Metabolomics-Based Intervention of Yanghe Decoction on Hashimoto's Thyroiditis.

Zhang X, Chen D, Xu K, Ma Z. Zhang X, et al. Among authors: xu k. Evid Based Complement Alternat Med. 2022 Jul 15;2022:6215573. doi: 10.1155/2022/6215573. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35873647 Free PMC article.

7

BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.

Wang X, Xu Y, Xu K, Chen Y, Xiao X, Guan X. Wang X, et al. Among authors: xu k, xu y. Oncol Lett. 2020 Apr;19(4):2916-2924. doi: 10.3892/ol.2020.11383. Epub 2020 Feb 10. Oncol Lett. 2020. PMID: 32218847 Free PMC article.

8

Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.

He L, Guo S, Zhu T, Chen C, Xu K. He L, et al. Among authors: xu k. Med Sci Monit. 2020 Jun 28;26:e922561. doi: 10.12659/MSM.922561. Med Sci Monit. 2020. PMID: 32594094 Free PMC article.

9

Silencing of AFAP1-AS1 lncRNA impairs cell proliferation and migration by epigenetically promoting DUSP5 expression in pre-eclampsia.

Zhang S, Zou Y, Tang X, Zhang Y, Yang N, Xu K, Xu Y. Zhang S, et al. Among authors: xu k, xu y. J Cell Biochem. 2021 Oct;122(10):1506-1516. doi: 10.1002/jcb.30072. Epub 2021 Jun 30. J Cell Biochem. 2021. PMID: 34192359

10

Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer.

Xu F, Xu K, Fan L, Li X, Liu Y, Yang F, Zhu C, Guan X. Xu F, et al. Among authors: xu k. Chin Med J (Engl). 2024 Feb 5;137(3):338-349. doi: 10.1097/CM9.0000000000002930. Epub 2023 Dec 15. Chin Med J (Engl). 2024. PMID: 38105538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,720 results

Search Page

Filters